Showing all 14 results
Cyclophosphamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Prodrug Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the sensitive nitrogen mustard derivative and to physically protect caregivers from API exposure.
Active Ingredient Strength Primary Clinical Function Cyclophosphamide USP/Ph.Eur.
(as Cyclophosphamide Monohydrate)50 mg The Oncology & Autoimmune Macrodose: The definitive oral therapeutic unit utilized for chronic, daily continuous “metronomic” chemotherapy regimens and severe immunosuppressive maintenance. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Starch / Magnesium Stearate / Heavy Sucrose or Polymeric Film-Coat Diluent / Densifier / Disintegrant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing a thick, impenetrable sugar or film coat to ensure the highly toxic API never comes into contact with the skin of the patient, pharmacist, or caregiver handling the pill) *Pack Sizes: Bottles of 50/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic oncology and rheumatology dispensing regimens).
Ethinyestradiol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the synthetic steroidal API.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.05 mg (50 mcg) The Endocrinology Standard: The definitive micro-dose engineered specifically for female hypogonadism, primary ovarian failure, and strictly monitored estrogen replacement. Ethinylestradiol USP/Ph.Eur. 1 mg The Palliative Oncology Macrodose: Massive therapeutic payload utilized strictly for the aggressive hormonal suppression of advanced, inoperable prostate or breast cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the potent steroidal API, ensuring absolute safety for handlers and guaranteeing zero cross-contamination in the facility) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrine and oncology dispensing regimens).
Everolimus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Antioxidant-Stabilized Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the highly oxidative, potent API.
Active Ingredient Strength Primary Clinical Function Everolimus USP/Ph.Eur. 0.25 mg / 0.5 mg / 0.75 mg Global Transplant Standard: Ultra-micro doses utilized for strict, lifelong immunosuppression following renal or hepatic allografts. Requires extreme content uniformity to maintain the narrow therapeutic blood trough levels (3 to 8 ng/mL). Everolimus USP/Ph.Eur. 5 mg / 10 mg Global Oncology Standard: Massive-dose antineoplastic payload utilized for the aggressive suppression of Renal Cell Carcinoma, Neuroendocrine Tumors (NETs), and HR+/HER2- Breast Cancer. Excipients Butylated Hydroxytoluene (BHT) / Hypromellose / Lactose Anhydrous / Crospovidone / Magnesium Stearate Antioxidant / Binder / Diluent / Superdisintegrant / Lubricant (Engineered specifically utilizing BHT (Butylated Hydroxytoluene) to prevent the rapid oxidative degradation of the Everolimus molecule, guaranteeing maximum clinical shelf-life and potency across harsh climates) *Pack Sizes: 10×10 Alu-Alu Blisters (Transplant) or 3×10 Alu-Alu Blisters (Oncology – 30 Day Supply).
Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Imatinib tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the mesylate salt.
Active Ingredient Strength Primary Clinical Function Imatinib (as Mesylate) USP/Ph.Eur. 100 mg Pediatric & Titration Standard: Base therapeutic unit utilized for weight-based pediatric leukemia dosing, or for highly precise adult dose adjustments during acute hematological toxicity. Imatinib (as Mesylate) USP/Ph.Eur. 400 mg Global Adult Oncology Standard: High-efficacy adult maintenance dose, typically taken once daily for the chronic phase of CML, or twice daily for accelerated phases and GIST. Excipients Microcrystalline Cellulose / Crospovidone / Hypromellose / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Iron-Oxide Film Diluent / Superdisintegrant / Binder / Glidant / Heavy Film-Coating (Engineered specifically to lock the cytotoxic API safely inside the tablet, completely preventing handler and pharmacist exposure to the carcinogenic dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Letrozole tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micro-dosed endocrine disruptor.
Active Ingredient Strength Primary Clinical Function Letrozole USP/Ph.Eur. 2.5 mg Global Oncology & Fertility Standard: The universal therapeutic unit utilized for 5-to-10 year daily adjuvant breast cancer therapy, or short 5-day cyclic dosing for ovulation induction. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically using elite geometric dilution to ensure the microscopic 2.5mg active payload is flawlessly distributed throughout the tablet, guaranteeing absolute content uniformity) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, heavily monitored chronic oncology dispensing or monthly fertility cycles).
Melphalan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, handler-protective Amber Glass Bottles or specialized Alu-Alu cold-chain blisters to ensure the absolute chemical survival of the highly unstable alkylating agent.
Active Ingredient Strength Primary Clinical Function Melphalan USP/Ph.Eur. 2 mg Global Oncology Standard: Base therapeutic unit allowing for highly precise, weight-based or Body Surface Area (BSA) calculated “pulsed” dosing regimens. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically with a heavy film-coat to ensure immediate gastric transit and to completely seal the highly toxic, mutagenic core away from nurses and caregivers) *Pack Sizes: Amber Glass Bottles of 25/50 Tablets (Optimized specifically for strict, highly monitored hematology dispensing regimens).
Methotrexate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, handler-protective Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antimetabolite.
Active Ingredient Strength Primary Clinical Function Methotrexate USP/Ph.Eur. 2.5 mg Global Autoimmune Standard: The absolute foundational unit for Rheumatoid Arthritis and Psoriasis, allowing for highly precise, incremental dose titration. Methotrexate USP/Ph.Eur. 5 mg / 7.5 mg / 10 mg Escalated / Oncology Standard: Higher-dose units for severe, refractory autoimmune disease, Choriocarcinoma, and maintenance therapy in Acute Lymphoblastic Leukemia (ALL). Excipients Lactose Monohydrate / Maize Starch / Pregelatinized Starch / Magnesium Stearate Diluent / Binder / Disintegrant / Lubricant (Engineered specifically using high-containment wet granulation to prevent airborne cytotoxic dust generation during manufacturing, ensuring precise, even API distribution) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, heavily monitored chronic dispensing regimens).
Morphine Sulphate SR Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Morphine Sulphate USP/Ph.Eur. 15 mg (SR) Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management. Morphine Sulphate USP/Ph.Eur. 30 mg / 60 mg (SR) Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain. Excipients Hypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded Film Hydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).
Ondansitron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Flash-Dispersion ODT or Standard Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant peelable Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic ODT matrix.
Active Ingredient Strength Primary Clinical Function Ondansetron (as HCl Dihydrate) Ph.Eur./USP 4 mg (ODT / FCT) Pediatric & PONV Standard: Base therapeutic unit for post-operative nausea, severe pediatric gastroenteritis, and mild emetic triggers. Ondansetron (as HCl Dihydrate) Ph.Eur./USP 8 mg (ODT / FCT) Global Oncology Standard: High-dose adult maintenance therapy for highly emetogenic chemotherapy (CINV) and radiation therapy (RINV). Excipients (ODT Formulation) Mannitol / Crospovidone / Aspartame / Colloidal Silicon Dioxide / Premium Mint Flavoring Lyophilized Matrix / Superdisintegrant / Sweetener / Saliva-Stimulating Flavor (Engineered specifically to draw saliva into the tablet matrix, forcing a violent, sub-5-second structural collapse on the tongue without a bitter aftertaste) *Pack Sizes: 10×10 Peelable Alu-Alu Blisters (Optimized specifically for strict oncology and surgical dispensing regimens).
Pazopanib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.
Active Ingredient Strength Primary Clinical Function Pazopanib HCl INN/Ph.Eur. 200 mg (Base Equivalent) Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions. Pazopanib HCl INN/Ph.Eur. 400 mg (Base Equivalent) Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure) *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Sorafenib tablets 200mg
FreeA Sorafenib 200mg tablet is an oral multi-kinase inhibitor primarily containing Sorafenib as the active substance. It is used as a targeted therapy to treat advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma), and certain types of thyroid cancer.
Tamoxifen citrate Tablets
FreeA Tamoxifen citrate tablet is a selective estrogen receptor modulator (SERM) typically prescribed for the treatment and prevention of hormone receptor-positive breast cancer.
Tamoxifen Tablet
FreeA Tamoxifen tablet is a hormone-based medication used primarily to treat and prevent hormone receptor-positive breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs)
